Table of Content

Table of Contents

Global Gastrointestinal Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Gastrointestinal Drugs Market by Value
2.2.1 Global Gastrointestinal Drugs Revenue by Type
2.2.2 Global Gastrointestinal Drugs Market by Value (%)
2.3 Global Gastrointestinal Drugs Market by Production
2.3.1 Global Gastrointestinal Drugs Production by Type
2.3.2 Global Gastrointestinal Drugs Market by Production (%)

3. The Major Driver of Gastrointestinal Drugs Industry
3.1 Historical & Forecast Global Gastrointestinal Drugs Demand
3.2 Largest Application for Gastrointestinal Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Gastrointestinal Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Gastrointestinal Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Gastrointestinal Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Gastrointestinal Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Gastrointestinal Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Gastrointestinal Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Gastrointestinal Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Gastrointestinal Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Gastrointestinal Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Gastrointestinal Drugs Average Price Trend
12.1 Market Price for Each Type of Gastrointestinal Drugs in US (2018-2022)
12.2 Market Price for Each Type of Gastrointestinal Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Gastrointestinal Drugs in China (2018-2022)
12.4 Market Price for Each Type of Gastrointestinal Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Gastrointestinal Drugs in India (2018-2022)
12.6 Market Price for Each Type of Gastrointestinal Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Gastrointestinal Drugs in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Gastrointestinal Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Gastrointestinal Drugs

14. Gastrointestinal Drugs Competitive Landscape
14.1 Abbott Laboratories
14.1.1 Abbott Laboratories Company Profiles
14.1.2 Abbott Laboratories Product Introduction
14.1.3 Abbott Laboratories Gastrointestinal Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Allergan
14.2.1 Allergan Company Profiles
14.2.2 Allergan Product Introduction
14.2.3 Allergan Gastrointestinal Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 AstraZeneca
14.3.1 AstraZeneca Company Profiles
14.3.2 AstraZeneca Product Introduction
14.3.3 AstraZeneca Gastrointestinal Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Bayer
14.4.1 Bayer Company Profiles
14.4.2 Bayer Product Introduction
14.4.3 Bayer Gastrointestinal Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Boehringer Ingelheim
14.5.1 Boehringer Ingelheim Company Profiles
14.5.2 Boehringer Ingelheim Product Introduction
14.5.3 Boehringer Ingelheim Gastrointestinal Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 GlaxoSmithKline
14.6.1 GlaxoSmithKline Company Profiles
14.6.2 GlaxoSmithKline Product Introduction
14.6.3 GlaxoSmithKline Gastrointestinal Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Janssen Biotech
14.7.1 Janssen Biotech Company Profiles
14.7.2 Janssen Biotech Product Introduction
14.7.3 Janssen Biotech Gastrointestinal Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Sanofi
14.8.1 Sanofi Company Profiles
14.8.2 Sanofi Product Introduction
14.8.3 Sanofi Gastrointestinal Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Takeda Pharmaceutical
14.9.1 Takeda Pharmaceutical Company Profiles
14.9.2 Takeda Pharmaceutical Product Introduction
14.9.3 Takeda Pharmaceutical Gastrointestinal Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Valeant Pharmaceuticals
14.10.1 Valeant Pharmaceuticals Company Profiles
14.10.2 Valeant Pharmaceuticals Product Introduction
14.10.3 Valeant Pharmaceuticals Gastrointestinal Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Gastrointestinal Drugs Industry (Volume)
Figure 2. Gastrointestinal Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Gastrointestinal Drugs Revenue in 2022
Figure 5. US Gastrointestinal Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Gastrointestinal Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Gastrointestinal Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Gastrointestinal Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Gastrointestinal Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Gastrointestinal Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Gastrointestinal Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Gastrointestinal Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Gastrointestinal Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Gastrointestinal Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Gastrointestinal Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Gastrointestinal Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Gastrointestinal Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Gastrointestinal Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Gastrointestinal Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Gastrointestinal Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Gastrointestinal Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Gastrointestinal Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Gastrointestinal Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Gastrointestinal Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Abbott Laboratories Profiles
Table 61. Abbott Laboratories Gastrointestinal Drugs Product Introduction
Table 62. Abbott Laboratories Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Abbott Laboratories Strategic initiatives
Table 64. Allergan Profiles
Table 65. Allergan Gastrointestinal Drugs Product Introduction
Table 66. Allergan Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Allergan Strategic initiatives
Table 68. AstraZeneca Profiles
Table 69. AstraZeneca Gastrointestinal Drugs Product Introduction
Table 70. AstraZeneca Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. AstraZeneca Strategic initiatives
Table 72. Bayer Profiles
Table 73. Bayer Gastrointestinal Drugs Product Introduction
Table 74. Bayer Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Bayer Strategic initiatives
Table 76. Boehringer Ingelheim Profiles
Table 77. Boehringer Ingelheim Gastrointestinal Drugs Product Introduction
Table 78. Boehringer Ingelheim Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Boehringer Ingelheim Strategic initiatives
Table 80. GlaxoSmithKline Profiles
Table 81. GlaxoSmithKline Gastrointestinal Drugs Product Introduction
Table 82. GlaxoSmithKline Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. GlaxoSmithKline Strategic initiatives
Table 84. Janssen Biotech Profiles
Table 85. Janssen Biotech Gastrointestinal Drugs Product Introduction
Table 86. Janssen Biotech Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Janssen Biotech Strategic initiatives
Table 88. Sanofi Profiles
Table 89. Sanofi Gastrointestinal Drugs Product Introduction
Table 90. Sanofi Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Sanofi Strategic initiatives
Table 92. Takeda Pharmaceutical Profiles
Table 93. Takeda Pharmaceutical Gastrointestinal Drugs Product Introduction
Table 94. Takeda Pharmaceutical Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Takeda Pharmaceutical Strategic initiatives
Table 97. Valeant Pharmaceuticals Profiles
Table 98. Valeant Pharmaceuticals Gastrointestinal Drugs Product Introduction
Table 99. Valeant Pharmaceuticals Gastrointestinal Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Valeant Pharmaceuticals Strategic initiatives